PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-11

Date Title Company
11-Nov-2024 Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) Autolus Therapeutics
11-Nov-2024 Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma Johnson & Johnson
11-Nov-2024 AstraZeneca and Amgen’s Tezspire meets both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps AstraZeneca
11-Nov-2024 ACG Inspection launches Life Sciences Cloud ACG Inspection
11-Nov-2024 Moberg Pharma’s Nomination Committee appointed Moberg Pharma
11-Nov-2024 Transgene Reports Business, Pipeline and Financial Update for Q3 2024 Transgene
11-Nov-2024 Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Transgene
11-Nov-2024 Ebenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board Ebenbuild
11-Nov-2024 Angle PLC Announces Parsortix enriched CTC & ctDNA in NSCLC patients AccessWire
11-Nov-2024 Hemogenyx Pharmaceuticals PLC Announces Institutional Investment AccessWire
11-Nov-2024 Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa AccessWire
11-Nov-2024 Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa Relief Therapeutics Holding SA
11-Nov-2024 Global Continuous Peripheral Nerve Block Catheter Market to Witness Remarkable Growth, Projected to Reach USD 1,058.6 Million by 2033 MARKITWIRED
11-Nov-2024 Global Hepatitis B Diagnostic Tests Market Poised for Significant Growth, Projected to Reach USD 1,744.26 Million by 2033 MARKITWIRED